Education
About Us
Working with TipRanks
Follow Us
Compass Therapeutics (CMPX)
NASDAQ:CMPX
Ctx-8371
Non Small Cell Lung Cancer, Triple Negative Breast Cancer, Head And Neck Squamous Cell Carcinoma, Malignant Melanoma, Hodgkin Lymphoma
Phase I
Recruiting
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Nov 17, 2023
―
Ctx-009
Metastatic Colorectal Cancer, Colon Cancer, Rectal Cancer
Phase II
Completed
A Study of CTX-009 in Adult Patients With Metastatic Colorectal Cancer
Aug 22, 2022
―
Paclitaxel, Ctx-009
Biliary Tract Cancer, Cholangiocarcinoma, Gall Bladder Cancer, Ampullary Cancer
Phase II/III
Active Not Recruiting
A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)
Aug 15, 2022
―
Irinotecan, Paclitaxel, Ctx-009 (Abl001)
P1b: Advanced Solid Tumors, P2: Biliary Tract Cancer
Phase I/II
Terminated
A Study of CTX-009 (ABL001) in Combination With Irinotecan or Paclitaxel in Advanced or Metastatic Solid Tumor Patients
Jun 15, 2020
―
Pembrolizumab (Keytruda®), Ctx-471
Melanoma, Non-small Cell Lung Cancer, Small Cell Lung Cancer, Metastatic Cancer, Head And Neck Cancer, Mesothelioma, Locally Advanced Solid Tumor
Phase I
Completed
Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies
Mar 13, 2019
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Compass Therapeutics (CMPX) have in its pipeline
CMPX is currently developing the following drugs: Ctx-8371, Ctx-009, Paclitaxel, Ctx-009. These drug candidates are in various stages of clinical development as the company works toward FDA approval.